{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:20Z","timestamp":1786996040848,"version":"build-2736575974"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.prp.2024.155769","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T12:17:20Z","timestamp":1734092240000},"page":"155769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["MicroRNAs and long non-coding RNAs In T-cell lymphoma: Mechanisms, pathway, therapeutic opportunities"],"prefix":"10.1016","volume":"266","author":[{"given":"Mohammed H.","family":"Abu-Alghayth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Abalkhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hazazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Alyahyawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Abdulaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somia A.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir Ibrahim A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan F.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3024-8494","authenticated-orcid":false,"given":"Humood Al","family":"Shmrany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1019-2467","authenticated-orcid":false,"given":"Farhan R.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.prp.2024.155769_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/17474086.2019.1647777","article-title":"Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic\/dendritic cell neoplasms","volume":"12","author":"Satou","year":"2019","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.prp.2024.155769_bib2","article-title":"Treasure Island (FL) ineligible companies. Disclosure: Saud Alsubait declares no relevant financial relationships with ineligible companies.: StatPearls PublishingCopyright \u00a9","volume":"2024","author":"Varghese","year":"2024"},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib3","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","article-title":"NK-\/T-cell lymphomas","volume":"35","author":"Wang","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/PPO.0000000000000451","article-title":"Lymphoma classification","volume":"26","author":"de Leval","year":"2020","journal-title":"Cancer J."},{"issue":"16","key":"10.1016\/j.prp.2024.155769_bib5","first-page":"1703","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood\u00a0J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-021-00296-9","article-title":"Cutaneous T cell lymphoma","volume":"7","author":"Dummer","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib7","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.3390\/cancers14092332","article-title":"Peripheral T-cell lymphomas: therapeutic approaches","volume":"14","author":"Sibon","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.prp.2024.155769_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/ajcp\/aqab012","article-title":"How I diagnose anaplastic large cell lymphoma","volume":"155","author":"Amador","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2024.155769_bib9","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","article-title":"Advances in understanding of angioimmunoblastic T-cell lymphoma","volume":"34","author":"Chiba","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib10","first-page":"34","article-title":"Lymphoma: diagnosis and treatment","volume":"101","author":"Lewis","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.prp.2024.155769_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.htct.2020.09.146","article-title":"Peripheral lymphocytosis presenting as EBV\/HTLV-1 co-infection adult T-cell leukemia","volume":"44","author":"Kasinathan","year":"2022","journal-title":"Hematol.\u00a0Transfus. Cell Ther."},{"key":"10.1016\/j.prp.2024.155769_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111974","article-title":"Tumorigenesis and diagnostic practice applied in two oncogenic viruses: epstein Barr virus and T-cell lymphotropic virus-1\u2014mini review","volume":"142","author":"Manivannan","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155769_bib13","series-title":"Seminars in Cancer Biology","article-title":"editors. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways","author":"Patil","year":"2022"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-pathol-020117-043821","article-title":"Pathogenesis of peripheral T cell lymphoma","volume":"13","author":"Pizzi","year":"2018","journal-title":"Annu. Rev. Pathol.\u00a0Mech. Dis."},{"key":"10.1016\/j.prp.2024.155769_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/bs.ircmb.2023.04.004","article-title":"Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma","volume":"380","author":"Adeeb","year":"2023","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3390\/cancers12051229","article-title":"MicroRNAs in the pathogenesis, diagnosis, prognosis and targeted treatment of cutaneous T-cell lymphomas","volume":"12","author":"Gluud","year":"2020","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.prp.2024.155769_bib18","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.7150\/jca.58859","article-title":"Potential impact and mechanism of Long Non-coding RNAs on cancer and associated T cells","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1634\/theoncologist.2017-0524","article-title":"Recent advances in the treatment of peripheral T-cell lymphoma","volume":"23","author":"Laribi","year":"2018","journal-title":"oncologist"},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jcyt.2019.04.058","article-title":"T-cell therapies for T-cell lymphoma","volume":"21","author":"Toner","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.prp.2024.155769_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997482","article-title":"Treatment of aggressive T-cell lymphoma\/leukemia with anti-CD4 CAR T cells","volume":"13","author":"Feng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2024.155769_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102793","article-title":"Peripheral T-cell lymphoma: from biology to practice to the future","author":"O'Connor","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.prp.2024.155769_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719841581","article-title":"CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products","volume":"10","author":"Chavez","year":"2019","journal-title":"Ther. Adv. Hematol."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11427-022-2171-2","article-title":"RNA therapeutics: updates and future potential","volume":"66","author":"Zhang","year":"2023","journal-title":"Sci. China Life Sci."},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib25","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/jcm9020593","article-title":"Role of non-coding RNAs in the development of targeted therapy and immunotherapy approaches for chronic lymphocytic leukemia","volume":"9","author":"Pepe","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.prp.2024.155769_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.prp.2024.155769_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","article-title":"The roles of microRNAs in epigenetic regulation","volume":"51","author":"Yao","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib28","first-page":"2735","article-title":"MicroRNAs and cancer: key paradigms in molecular therapy","volume":"15","author":"Tan","year":"2018","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/febs.15493","article-title":"Differential roles of miR-15a\/16-1 and miR-497\/195 clusters in immune cell development and homeostasis","volume":"288","author":"Hutter","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.prp.2024.155769_bib30","article-title":"Diagnostic value of circulating miR-155 for breast cancer: a meta-analysis","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/15384047.2018.1504721","article-title":"MiRNA-155 regulates lymphangiogenesis in natural killer\/T-cell lymphoma by targeting BRG1","volume":"20","author":"Chang","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"7","key":"10.1016\/j.prp.2024.155769_bib32","doi-asserted-by":"crossref","first-page":"10749","DOI":"10.18632\/aging.202895","article-title":"Dual activation of Hedgehog and Wnt\/\u03b2-catenin signaling pathway caused by downregulation of SUFU targeted by miRNA-150 in human gastric cancer","volume":"13","author":"Peng","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.prp.2024.155769_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0639-5","article-title":"MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK\/T cell lymphoma","volume":"37","author":"Wu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2024.155769_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ncrna.2024.03.013","article-title":"microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: a narrative review","author":"Giordo","year":"2024","journal-title":"Non-coding RNA Res."},{"issue":"21","key":"10.1016\/j.prp.2024.155769_bib35","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.3390\/cancers13215565","article-title":"MicroRNA-21 plays multiple oncometabolic roles in colitis-associated carcinoma and colorectal cancer via the PI3K\/AKT, STAT3, and PDCD4\/TNF-\u03b1 signaling pathways in zebrafish","volume":"13","author":"Lai","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155769_bib36","article-title":"Down-regulating the expression of miRNA-21 inhibits the glucose metabolism of A549\/DDP cells and promotes cell death through the PI3K\/AKT\/mTOR\/HIF-1\u03b1 pathway","volume":"11","author":"Sun","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2024.155769_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fonc.2019.00515","article-title":"Non-coding RNAs in natural killer\/T-cell lymphoma","volume":"9","author":"Mei","year":"2019","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2024.155769_bib38","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ijms20081816","article-title":"MicroRNA-214-3p targeting Ctnnb1 promotes 3T3-L1 preadipocyte differentiation by interfering with the Wnt\/\u03b2-catenin signaling pathway","volume":"20","author":"Xi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155769_bib39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.biopha.2018.05.149","article-title":"MiR-214 promotes cell meastasis and inhibites apoptosis of esophageal squamous cell carcinoma via PI3K\/AKT\/mTOR signaling pathway","volume":"105","author":"Guanen","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41389-019-0151-1","article-title":"Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer","volume":"8","author":"Yang","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.prp.2024.155769_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100821","article-title":"Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1\u03b1\/miR-494\/Survivin signaling pathway","volume":"32","author":"Li","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.prp.2024.155769_bib42","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2147\/OTT.S278233","article-title":"LncRNA WT1-AS\/miR-494-3p regulates cell proliferation, apoptosis, migration and invasion via PTEN\/PI3K\/AKT signaling pathway in non-small cell lung cancer","author":"Wu","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2024.155769_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01231-w","article-title":"Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a\/PI3K\/Akt\/mTOR axis","volume":"20","author":"Peng","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib44","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.7150\/thno.40566","article-title":"A miR-146a-5p\/TRAF6\/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance","volume":"10","author":"Meng","year":"2020","journal-title":"Theranostics"},{"issue":"25","key":"10.1016\/j.prp.2024.155769_bib45","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/s41388-017-0088-9","article-title":"MicroRNA-146b promotes PI3K\/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN","volume":"37","author":"Ramirez-Moya","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2024.155769_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.913951","article-title":"OncomiRs as noncoding RNAs having functions in cancer: their role in immune suppression and clinical implications","volume":"13","author":"Otmani","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.prp.2024.155769_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.708765","article-title":"Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications","volume":"11","author":"Otmani","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2024.155769_bib48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","article-title":"The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics","volume":"20","author":"Bautista-S\u00e1nchez","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/1724600819843537","article-title":"Clinical significance of tumor miR-21, miR-221, miR-143, and miR-106a as biomarkers in patients with osteosarcoma","volume":"34","author":"Zhao","year":"2019","journal-title":"Int. J. Biol. Markers"},{"issue":"18","key":"10.1016\/j.prp.2024.155769_bib50","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3390\/cells11182791","article-title":"From molecular mechanisms to therapeutics: understanding MicroRNA-21 in cancer","volume":"11","author":"Rhim","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib51","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.3390\/cells9092053","article-title":"Impact of bone marrow miR-21 expression on acute myeloid leukemia T lymphocyte fragility and dysfunction","volume":"9","author":"Moussa Agha","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib52","first-page":"89","article-title":"MicroRNA-21 and microRNA-155 promote the progression of Burkitt\u2019s lymphoma by the PI3K\/AKT signaling pathway.","volume":"13","author":"Han","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.prp.2024.155769_bib53","unstructured":"Bautista-S\u00e1nchez D., Arriaga-Canon C., Pedroza-Torres A., De La Rosa-Vel\u00e1zquez I.A., Gonz\u00e1lez-Barrios R., Contreras-Espinosa L., et al. The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3349\/ymj.2020.61.1.20","article-title":"Curcumin inhibits the proliferation, migration, invasion, and apoptosis of diffuse large B-cell lymphoma cell line by regulating MiR-21\/VHL axis","volume":"61","author":"Chen","year":"2020","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.prp.2024.155769_bib55","unstructured":"Sims E.K. Microrna 21 targets B Cell Lymphoma 2 (Bcl2) Mrna to increase beta cell apoptosis and exosomal Microrna 21 could serve as a biomarker of developing Type 1 Diabetes Mellitus. 2018."},{"key":"10.1016\/j.prp.2024.155769_bib56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.canlet.2018.02.035","article-title":"Diverse functions of miR-17\u201392 cluster microRNAs in T helper cells","volume":"423","author":"Baumjohann","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib57","article-title":"The MicroRNA family both in normal development and in different diseases: the miR-17-92 cluster","volume":"2019","author":"Bai","year":"2019","journal-title":"BioMed. Res. Int."},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.molcel.2019.05.033","article-title":"Oncogenic biogenesis of pri-miR-17\u223c 92 reveals hierarchy and competition among polycistronic MicroRNAs","volume":"75","author":"Donayo","year":"2019","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib59","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3390\/ijms19030879","article-title":"The oncogenic relevance of miR-17-92 cluster and its paralogous miR-106b-25 and miR-106a-363 clusters in brain tumors","volume":"19","author":"Gruszka","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155769_bib60","article-title":"The miR-17-92 cluster: yin and Yang in human cancers","volume":"33","author":"Zhao","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"issue":"6","key":"10.1016\/j.prp.2024.155769_bib61","doi-asserted-by":"crossref","DOI":"10.1530\/REP-17-0603","article-title":"MicroRNAs: crucial regulators of placental development","volume":"155","author":"Hayder","year":"2018","journal-title":"Reproduction"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12672-023-00775-3","article-title":"miR-17\u223c 92 suppresses proliferation and invasion of cervical cancer cells by inhibiting cell cycle regulator Cdt2","volume":"14","author":"Singh","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.prp.2024.155769_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2018.12.020","article-title":"miR-17\u223c 92 in lymphocyte development and lymphomagenesis","volume":"446","author":"Labi","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib64","article-title":"The emerging role of microRNAs in breast cancer","volume":"2020","author":"Yang","year":"2020","journal-title":"J. Oncol."},{"key":"10.1016\/j.prp.2024.155769_bib65","doi-asserted-by":"crossref","first-page":"148829","DOI":"10.1016\/j.gene.2024.148829","article-title":"The role of MiRNA-34 family in different signaling pathways and its therapeutic options","volume":"931","author":"Yahya","year":"2024","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.prp.2024.155769_bib66","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/diagnostics10080563","article-title":"Multifunctional roles of miR-34a in cancer: a review with the emphasis on head and neck squamous cell carcinoma and thyroid cancer with clinical implications","volume":"10","author":"Kalfert","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.prp.2024.155769_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1134\/S106816202001015X","article-title":"The fundamentals of miRNA biology: structure, biogenesis, and regulatory functions","volume":"46","author":"Zaporozhchenko","year":"2020","journal-title":"Russ. J. Bioorg. Chem."},{"issue":"40","key":"10.1016\/j.prp.2024.155769_bib68","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1038\/s41388-023-02801-8","article-title":"A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy","volume":"42","author":"Abdelaal","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2024.155769_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118209","article-title":"Regulatory and immunomodulatory role of miR-34a in T cell immunity","volume":"262","author":"Taheri","year":"2020","journal-title":"Life Sci."},{"issue":"24","key":"10.1016\/j.prp.2024.155769_bib70","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.3390\/ijms222413550","article-title":"MicroRNAs regulate cell cycle and cell death pathways in glioblastoma","volume":"22","author":"Sati","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155769_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111528","article-title":"MicroRNA: a signature for cancer progression","volume":"138","author":"Hussen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib72","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10555-021-09973-3","article-title":"The comprehensive landscape of miR-34a in cancer research","volume":"40","author":"Li","year":"2021","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"10","key":"10.1016\/j.prp.2024.155769_bib73","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.3390\/ijms23105486","article-title":"Role of miRNAs in human T cell leukemia virus type 1 induced T cell leukemia: a literature review and bioinformatics approach","volume":"23","author":"Machado","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib74","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1002\/jcp.27342","article-title":"The miR-15a\/16 gene cluster in human cancer: a systematic review","volume":"234","author":"Liu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.prp.2024.155769_bib75","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopha.2018.05.041","article-title":"miR-15a\/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-\u03b2 signaling pathway.","volume":"104","author":"Jin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155769_bib76","doi-asserted-by":"crossref","unstructured":"Hong Y., He W., Zhang J., Shen L., Yu C., Yan L., et al. Cyclin D3-CDK6 Complex Facilitates Tumorigenesis by Regulating the C-Myc\/miR-15a\/16 Axis in a Feedback Loop in Gastric Cancer. 2020.","DOI":"10.21203\/rs.3.rs-125333\/v1"},{"issue":"6","key":"10.1016\/j.prp.2024.155769_bib77","doi-asserted-by":"crossref","first-page":"192","DOI":"10.31083\/j.fbl2706192","article-title":"The role and mechanisms of action of natural compounds in the prevention and treatment of cancer and cancer metastasis","volume":"27","author":"Wang","year":"2022","journal-title":"Front. Biosci. Landmark"},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib78","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3892\/ijmm.2020.4634","article-title":"Exosomal microRNA\u2011146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2\u2011mediated PI3K\/Akt axis","volume":"46","author":"Qiu","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.prp.2024.155769_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1230273","article-title":"Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles","volume":"13","author":"Mondal","year":"2023","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2024.155769_bib80","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-19-0087","article-title":"The NF-KB pathway and endocrine therapy resistance in breast cancer","volume":"26","author":"Khongthong","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib81","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.prp.2024.155769_bib82","doi-asserted-by":"crossref","DOI":"10.5772\/dmht.04","article-title":"T-Cell Receptor dependent and independent NF-kappa B activation is a prognostic marker and a therapeutic target in peripheral T-cell lymphoma not otherwise specified","author":"Navari","year":"2022","journal-title":"Digit. Med. Healthc. Technol."},{"key":"10.1016\/j.prp.2024.155769_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1129191","article-title":"NF\u03baB signaling in T cell memory","volume":"14","author":"Daniels","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/genes9010024","article-title":"NF-kappaB: two sides of the same coin","volume":"9","author":"Pires","year":"2018","journal-title":"Genes"},{"issue":"12","key":"10.1016\/j.prp.2024.155769_bib85","doi-asserted-by":"crossref","first-page":"10337","DOI":"10.3390\/ijms241210337","article-title":"The recent research progress of NF-\u03baB signaling on the proliferation, migration, invasion, immune escape and drug resistance of glioblastoma","volume":"24","author":"Shi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155769_bib86","first-page":"1252939","article-title":"Non-canonical NF-\u03baB signaling in immune-mediated inflammatory diseases and malignancies","author":"Tas","year":"2023","journal-title":"Front. Media SA"},{"key":"10.1016\/j.prp.2024.155769_bib87","series-title":"in Ribosomal Stress","article-title":"The Role of the Nuclear Factor-kappa B Subunit, p52","author":"Corbin","year":"2023"},{"key":"10.1016\/j.prp.2024.155769_bib88","unstructured":"Malu A. HTLV-1 Latency-Maintenance Factor p30II Modulates Tax-Induced NF-kappa B Signaling Through a p53-Regulated Mechanism. 2019."},{"key":"10.1016\/j.prp.2024.155769_bib89","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3389\/fimmu.2018.00546","article-title":"MicroRNA roles in the nuclear factor kappa B signaling pathway in cancer","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.prp.2024.155769_bib90","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/pathogens8040290","article-title":"NF-\u03baB and MicroRNA deregulation mediated by HTLV-1 tax and HBZ","volume":"8","author":"Fochi","year":"2019","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.prp.2024.155769_bib91","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.prp.2024.155769_bib92","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.gene.2019.02.076","article-title":"The relation between PI3K\/AKT signalling pathway and cancer","volume":"698","author":"Noorolyai","year":"2019","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib93","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbcan.2019.03.003","article-title":"Targeting PI3K signaling in cancer: challenges and advances","volume":"1871","author":"De Santis","year":"2019","journal-title":"Biochim. Et. Biophys. Acta BBA Rev. Cancer"},{"issue":"13","key":"10.1016\/j.prp.2024.155769_bib94","first-page":"1110","article-title":"Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma. Blood","volume":"138","author":"Xu","year":"2021","journal-title":"J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib95","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/ijms21031060","article-title":"Is there a role for dual PI3K\/mTOR inhibitors for patients affected with lymphoma?","volume":"21","author":"Tarantelli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.prp.2024.155769_bib96","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1515\/cclm-2018-0838","article-title":"The circulating miRNAs as diagnostic and prognostic markers","volume":"57","author":"Terrinoni","year":"2019","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib97","article-title":"Cluster miRNAs and cancer: diagnostic, prognostic and therapeutic opportunities","volume":"11","author":"Kabekkodu","year":"2020","journal-title":"Wiley Interdiscip. Rev.\u00a0RNA"},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib99","doi-asserted-by":"crossref","first-page":"34","DOI":"10.20892\/j.issn.2095-3941.2020.0216","article-title":"Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials","volume":"18","author":"Lai","year":"2021","journal-title":"Cancer Biol. Med."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib100","doi-asserted-by":"crossref","first-page":"5","DOI":"10.17816\/dv106327","article-title":"MicroRNA as a diagnostic marker in cutaneous T-cell lymphomas","volume":"25","author":"Olisova","year":"2022","journal-title":"Russ. J. Ski. Vener. Dis."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib101","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12935-024-03226-3","article-title":"MicroRNA expression signature as a biomarker in the diagnosis of nodal T-cell lymphomas","volume":"24","author":"Bin Masroni","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"10","key":"10.1016\/j.prp.2024.155769_bib102","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.3390\/ijms19102944","article-title":"Relevance of microRNAs as potential diagnostic and prognostic markers in colorectal cancer","volume":"19","author":"Hibner","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib103","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.21037\/tcr-20-1294","article-title":"MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers","volume":"9","author":"Sharma","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.prp.2024.155769_bib104","first-page":"1","article-title":"microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2024.155769_bib105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-018-3462-1","article-title":"Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1\u03b1-VEGF signaling pathway","volume":"454","author":"Sabry","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib106","first-page":"1666","article-title":"miR\u2011224\/miR\u2011141 ratio as a novel diagnostic biomarker in renal cell carcinoma","volume":"16","author":"Chen","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5114\/ceh.2020.93052","article-title":"The clinical significance of serum miRNA-224 expression in hepatocellular carcinoma","volume":"6","author":"Nomair","year":"2020","journal-title":"Clin. Exp. Hepatol."},{"issue":"15","key":"10.1016\/j.prp.2024.155769_bib108","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3748\/wjg.v25.i15.1890","article-title":"Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value","volume":"25","author":"Cui","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.prp.2024.155769_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23237","article-title":"Serum exosomal miR-378 upregulation is associated with poor prognosis in non\u2013small-cell lung cancer patients","volume":"34","author":"Zhang","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"12","key":"10.1016\/j.prp.2024.155769_bib110","article-title":"Effects of microRNA-378 on epithelial-mesenchymal transition, migration, invasion and prognosis in gastric carcinoma by targeting BMP2","volume":"23","author":"Yang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/etm.2021.10136","article-title":"Prognostic value of microRNA\u2011378 in esophageal cancer and its regulatory effect on tumor progression","volume":"22","author":"Jin","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.prp.2024.155769_bib112","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib113","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","article-title":"Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease","volume":"126","author":"Huang","year":"2020","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib114","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jid.2018.11.007","article-title":"A microRNA-29 mimic (Remlarsen) represses extracellular matrix expression and fibroplasia in the skin","volume":"139","author":"Gallant-Behm","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051782","article-title":"The complex network between MYC oncogene and microRNAs in gastric cancer: an overview","volume":"21","author":"Anauate","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155769_bib116","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","article-title":"MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside","volume":"15","author":"Ratti","year":"2020","journal-title":"Target. Oncol."},{"key":"10.1016\/j.prp.2024.155769_bib117","doi-asserted-by":"crossref","first-page":"12097","DOI":"10.2147\/OTT.S281810","article-title":"Non-coding RNAs in diffuse large B-cell lymphoma","author":"Shi","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2024.155769_bib118","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.2147\/CMAR.S169406","article-title":"MALAT1: a potential biomarker in cancer","author":"Li","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib119","doi-asserted-by":"crossref","first-page":"8144","DOI":"10.1002\/jcb.28093","article-title":"MEG3 affects the progression and chemoresistance of T-cell lymphoblastic lymphoma by suppressing epithelial-mesenchymal transition via the PI3K\/mTOR pathway","volume":"120","author":"Deng","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2024.155769_bib120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2147\/OTT.S196619","article-title":"lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p","author":"Zhang","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"11","key":"10.1016\/j.prp.2024.155769_bib121","first-page":"6977","article-title":"LncRNA MALAT-1 promotes growth and metastasis of epithelial ovarian cancer via sponging microrna-22","volume":"12","author":"Pei","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2024.155769_bib122","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2147\/CMAR.S243796","article-title":"LncRNA MALAT1 regulates the cell proliferation and cisplatin resistance in gastric cancer via PI3K\/AKT pathway","author":"Dai","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib123","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12935-022-02540-y","article-title":"MALAT1-related signaling pathways in colorectal cancer","volume":"22","author":"Xu","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"10","key":"10.1016\/j.prp.2024.155769_bib124","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41419-018-0962-6","article-title":"SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p\/VEGFA axis","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib125","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41420-021-00427-x","article-title":"Long non-coding RNA ZFAS1 is a major regulator of epithelial-mesenchymal transition through miR-200\/ZEB1\/E-cadherin, vimentin signaling in colon adenocarcinoma","volume":"7","author":"O\u2019Brien","year":"2021","journal-title":"Cell Death Discov."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib126","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41419-018-0882-5","article-title":"Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p\/GSK3\u03b2 signal pathway.","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2024.155769_bib127","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.omtn.2019.05.013","article-title":"SNHG5 promotes breast cancer proliferation by sponging the miR-154-5p\/PCNA axis","volume":"17","author":"Chi","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"6","key":"10.1016\/j.prp.2024.155769_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2020.12250","article-title":"lncRNA SNHG5 promotes cell proliferation, migration and invasion in oral squamous cell carcinoma by sponging miR\u2011655\u20113p\/FZD4 axis","volume":"20","author":"Yu","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155769_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-6662-5","article-title":"LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179\/HMGB3 axis","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2024.155769_bib130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/OTT.S184078","article-title":"LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p\/TRPC3 pathway","author":"Gao","year":"2018","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.prp.2024.155769_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.599070","article-title":"Long non-coding RNA X-inactive specific transcript mediates cell proliferation and intrusion by modulating the miR-497\/Bcl-w axis in extranodal natural killer\/T-cell lymphoma","volume":"8","author":"Liu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.prp.2024.155769_bib132","first-page":"3501","article-title":"The lncRNA XIST promotes the progression of breast cancer by sponging miR-125b-5p to modulate NLRC5","volume":"12","author":"Zong","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2024.155769_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1237723","article-title":"The landscape of lncRNAs in gastric cancer: from molecular mechanisms to potential clinical applications","volume":"14","author":"Silva","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib134","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211016211","article-title":"LncRNA XIST promotes liver cancer progression by acting as a molecular sponge of miR-200b-3p to regulate ZEB1\/2 expression","volume":"49","author":"Liu","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.prp.2024.155769_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109129","article-title":"Maternally expressed gene 3 (MEG3): a tumor suppressor long non coding RNA","volume":"118","author":"Ghafouri-Fard","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155769_bib136","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-019-00614-3","article-title":"MEG3: an oncogenic long non-coding RNA in different cancers","volume":"25","author":"Al-Rugeebah","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.prp.2024.155769_bib137","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2019.05.007","article-title":"Role of long non-coding RNAs in lymphoma: a systematic review and clinical perspectives","volume":"141","author":"Yang","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.prp.2024.155769_bib138","doi-asserted-by":"crossref","DOI":"10.5808\/GI.2018.16.4.e18","article-title":"Roles of oncogenic long non-coding RNAs in cancer development","volume":"16","author":"Do","year":"2018","journal-title":"Genom. Inform."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib139","first-page":"19","article-title":"MALAT1: a long non\u2011coding RNA highly associated with human cancers","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.26502\/jcsct.5079016","article-title":"The role of MALAT1 in cancer","volume":"3","author":"Chen","year":"2019","journal-title":"J. Cancer Sci. Clin. Ther."},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib141","article-title":"Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer","volume":"1875","author":"Goyal","year":"2021","journal-title":"Biochim. Et. Biophys. Acta BBA Rev. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib142","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3390\/cancers11020216","article-title":"New insights into long non-coding RNA MALAT1 in cancer and metastasis","volume":"11","author":"Sun","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155769_bib143","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fgene.2020.00093","article-title":"The oncogenic and tumor suppressive functions of the long noncoding RNA MALAT1: an emerging controversy","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2024.155769_bib144","article-title":"Epigenetic regulation of cutaneous T-cell lymphoma is mediated by dysregulated lncRNA MALAT1 through modulation of tumor microenvironment","volume":"12","author":"Guo","year":"2022","journal-title":"Front. Oncol."},{"issue":"5-6","key":"10.1016\/j.prp.2024.155769_bib145","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1002\/jcb.29591","article-title":"Emerging roles of HOTAIR in human cancer","volume":"121","author":"Yuan","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.prp.2024.155769_bib146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2019.12.028","article-title":"HOTAIR LncRNA: a novel oncogenic propellant in human cancer","volume":"503","author":"Rajagopal","year":"2020","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib147","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2015.07.001","article-title":"LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer","volume":"1856","author":"Bhan","year":"2015","journal-title":"Biochim. Et. Biophys. Acta BBA Rev. Cancer"},{"issue":"7","key":"10.1016\/j.prp.2024.155769_bib148","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050193","article-title":"HOTAIR lncRNA promotes epithelial\u2013mesenchymal transition by redistributing LSD1 at regulatory chromatin regions","volume":"22","author":"Jarroux","year":"2021","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib149","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1159\/000490131","article-title":"HOTAIR: an oncogenic long non-coding RNA in human cancer","volume":"47","author":"Tang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.prp.2024.155769_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111136","article-title":"HOTAIR interacts with PRC2 complex regulating the regional preadipocyte transcriptome and human fat distribution","volume":"40","author":"Kuo","year":"2022","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.prp.2024.155769_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.13119","article-title":"The HOTAIR lncRNA: a remarkable oncogenic promoter in human cancer metastasis","volume":"21","author":"Chen","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2024.155769_bib152","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2019.04.016","article-title":"HOX transcript antisense RNA (HOTAIR) in cancer","volume":"454","author":"Qu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2024.155769_bib153","doi-asserted-by":"crossref","first-page":"49","DOI":"10.18632\/oncoscience.563","article-title":"lncRNA HOTAIR functions and therapeutic perspectives","volume":"9","author":"Garbo","year":"2022","journal-title":"Oncoscience"},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib154","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/cancers13030570","article-title":"Functional interaction among lncRNA HOTAIR and microRNAs in cancer and other human diseases","volume":"13","author":"Cantile","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155769_bib155","article-title":"Retracted: Knockdown of long noncoding RNA HOTAIR inhibits cell growth of human lymphoma cells by upregulation of miR-148b","author":"Zhao","year":"2019","journal-title":"Wiley Online Libr."},{"key":"10.1016\/j.prp.2024.155769_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.712786","article-title":"Long non-coding RNAs in diagnosis, treatment, prognosis, and progression of glioma: a state-of-the-art review","volume":"11","author":"Momtazmanesh","year":"2021","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib157","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1002\/jcp.26544","article-title":"TUSC7: a novel tumor suppressor long non-coding RNA in human cancers","volume":"233","author":"Li","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib158","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jcp.29083","article-title":"Biological and clinical relevance of metastasis-associated long noncoding RNAs in esophageal squamous cell carcinoma: a systematic review","volume":"235","author":"Talebi","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib159","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3892\/ijmm.2020.4825","article-title":"lncRNA TUSC7 inhibits osteosarcoma progression through the miR\u2011181a\/RASSF6 axis","volume":"47","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2023.13675","article-title":"Advances in targeting of miR\u201110\u2011associated lncRNAs\/circRNAs for the management of cancer","volume":"25","author":"Gao","year":"2023","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib161","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1002\/jcb.27604","article-title":"Interaction of long noncoding RNA MEG3 with miRNAs: a reciprocal regulation","volume":"120","author":"Moradi","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"24","key":"10.1016\/j.prp.2024.155769_bib162","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.3390\/cancers14246032","article-title":"The biological roles and molecular mechanisms of long non-coding RNA MEG3 in the hallmarks of cancer","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155769_bib163","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.sbi.2017.10.013","article-title":"Complex regulatory mechanisms mediated by the interplay of multiple post-translational modifications","volume":"48","author":"Csizmok","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"4","key":"10.1016\/j.prp.2024.155769_bib164","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41419-021-03594-y","article-title":"A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.prp.2024.155769_bib165","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fonc.2020.00499","article-title":"EMT factors and metabolic pathways in cancer","volume":"10","author":"Georgakopoulos-Soares","year":"2020","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.prp.2024.155769_bib166","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/cells8101178","article-title":"Insights into biological role of LncRNAs in epithelial-mesenchymal transition","volume":"8","author":"Cheng","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.prp.2024.155769_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.688027","article-title":"Roles of long noncoding RNAs in conferring glioma progression and treatment","volume":"11","author":"Qin","year":"2021","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2024.155769_bib168","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/1535370219860207","article-title":"LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling","volume":"244","author":"Deng","year":"2019","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.prp.2024.155769_bib169","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpha.2019.05.004","article-title":"Research advances in the detection of miRNA","volume":"9","author":"Ye","year":"2019","journal-title":"J. Pharm. Anal."},{"issue":"D1","key":"10.1016\/j.prp.2024.155769_bib170","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab1035","article-title":"lncRNAfunc: a knowledgebase of lncRNA function in human cancer","volume":"50","author":"Yang","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib171","first-page":"1","article-title":"Noncoding RNAs in apoptosis: identification and function","volume":"46","author":"T\u00fcncel","year":"2022","journal-title":"Turk. J. Biol."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib172","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41420-021-00407-1","article-title":"Progress in understanding the role of lncRNA in programmed cell death","volume":"7","author":"Jiang","year":"2021","journal-title":"Cell Death Discov."},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib173","article-title":"Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network","volume":"13","author":"Zhang","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.prp.2024.155769_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.526850","article-title":"MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review","volume":"10","author":"Volovat","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2024.155769_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114672","article-title":"Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research","volume":"162","author":"Ma","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.prp.2024.155769_bib176","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.771552","article-title":"miRNA, lncRNA and circRNA: targeted molecules full of therapeutic prospects in the development of diabetic retinopathy","volume":"12","author":"Chang","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.prp.2024.155769_bib177","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1248\/bpb.b23-00668","article-title":"Icariin regulates EMT and stem cell-like character in breast cancer through modulating lncRNA NEAT1\/TGF\u03b2\/SMAD2 signaling pathway","volume":"47","author":"Song","year":"2024","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib178","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-023-05099-7","article-title":"Wnt\/\u03b2-catenin-driven EMT regulation in human cancers","volume":"81","author":"Xue","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.prp.2024.155769_bib179","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/biomedicines12081713","article-title":"Using microRNAs networks to understand pancreatic cancer\u2014a literature review","volume":"12","author":"Przybyszewski","year":"2024","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.prp.2024.155769_bib180","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317701648","article-title":"Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer\/T-cell lymphoma and establishes MIR155HG as a target of PRDM1","volume":"39","author":"Baytak","year":"2017","journal-title":"Tumor Biol."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib181","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.jid.2018.03.1500","article-title":"MicroRNA signatures in diagnosis and prognosis of cutaneous T-cell lymphoma","volume":"138","author":"Shen","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2024.155769_bib182","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3389\/fonc.2019.00901","article-title":"SNHG12: an LncRNA as a potential therapeutic target and biomarker for human cancer","volume":"9","author":"Tamang","year":"2019","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib183","doi-asserted-by":"crossref","DOI":"10.1515\/jib-2019-0027","article-title":"Non-coding RNAs and their integrated networks","volume":"16","author":"Zhang","year":"2019","journal-title":"J. Integr. Bioinforma."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib184","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00018-017-2626-6","article-title":"Interaction and cross-talk between non-coding RNAs","volume":"75","author":"Yamamura","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.prp.2024.155769_bib185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fgene.2020.00150","article-title":"Structure, regulation, and function of linear and circular long non-coding RNAs","volume":"11","author":"Qin","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2024.155769_bib186","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fonc.2019.00669","article-title":"Crosstalk between long non-coding RNAs, micro-RNAs and mRNAs: deciphering molecular mechanisms of master regulators in cancer","volume":"9","author":"L\u00f3pez-Urrutia","year":"2019","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib187","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.3390\/ijms24098095","article-title":"Interplay between LncRNAs and microRNAs in breast cancer","volume":"24","author":"Schwarzenbach","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.prp.2024.155769_bib188","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/1873-3468.13085","article-title":"Interactions between short and long noncoding RNAs","volume":"592","author":"Ulitsky","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2024.155769_bib189","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.biochi.2019.05.010","article-title":"Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer","volume":"163","author":"Tang","year":"2019","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib190","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jid.2018.10.035","article-title":"MicroRNAs in cutaneous T-cell lymphoma: the future of therapy","volume":"139","author":"Kohnken","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"24","key":"10.1016\/j.prp.2024.155769_bib191","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.3390\/cancers13246324","article-title":"miRNA-and lncRNA-based therapeutics for non-hodgkin\u2019s lymphoma: moving towards an RNA-guided precision medicine","volume":"13","author":"Fernandes","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib192","article-title":"Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.prp.2024.155769_bib193","doi-asserted-by":"crossref","first-page":"11502","DOI":"10.3390\/ijms231911502","article-title":"miRNA: a promising therapeutic target in cancer","volume":"23","author":"Menon","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155769_bib194","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omto.2022.03.005","article-title":"Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer","volume":"25","author":"Gandham","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12935-022-02778-6","article-title":"CAR-T cell combination therapy: the next revolution in cancer treatment","volume":"22","author":"Al-Haideri","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.prp.2024.155769_bib196","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jid.2019.01.033","article-title":"Preclinical targeting of MicroRNA-214 in cutaneous T-cell lymphoma","volume":"139","author":"Kohnken","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.prp.2024.155769_bib197","series-title":"Seminars in Cell & Developmental Biology","article-title":"editors. The cross-talk between miRNAs and JAK\/STAT pathway in cutaneous T cell lymphoma: Emphasis on therapeutic opportunities","author":"Patil","year":"2022"},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib198","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/3091760","article-title":"B-cell chronic lymphocytic leukemia and B-cell lymphomas: the key role of micro and long noncoding RNAs","volume":"2024","author":"Mohammadian","year":"2024","journal-title":"J. Clin. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib199","doi-asserted-by":"crossref","first-page":"4","DOI":"10.29245\/2767-5092\/2023\/1.1168","article-title":"The dawning of a new enterprise: RNA therapeutics for the skin","volume":"5","author":"Kieser","year":"2023","journal-title":"J. Dermatol. Ski. Sci."},{"issue":"7","key":"10.1016\/j.prp.2024.155769_bib200","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41419-022-05075-2","article-title":"RNA-based therapeutics: an overview and prospectus","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib201","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-023-01807-w","article-title":"The use of RNA-based treatments in the field of cancer immunotherapy","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2024.155769_bib202","first-page":"211","article-title":"The guideline of the design and validation of MiRNA mimics. MicroRNA and Cancer","author":"Wang","year":"2011","journal-title":"Methods Protoc."},{"issue":"23","key":"10.1016\/j.prp.2024.155769_bib203","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1038\/s41388-019-0746-1","article-title":"Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma","volume":"38","author":"V\u00e1zquez-Dom\u00ednguez","year":"2019","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.prp.2024.155769_bib204","article-title":"MiRNA-584 suppresses the progression of NK\/T-cell lymphoma by targeting FOXO1","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2024.155769_bib205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/10428194.2019.1654096","article-title":"Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK\/T-cell lymphoma","volume":"61","author":"Go","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2024.155769_bib206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-020-00074-4","article-title":"Strategies to target long non-coding RNAs in cancer treatment: progress and challenges","volume":"21","author":"Fathi Dizaji","year":"2020","journal-title":"Egypt. J. Med. Hum. Genet."},{"issue":"8","key":"10.1016\/j.prp.2024.155769_bib207","doi-asserted-by":"crossref","first-page":"12628","DOI":"10.1002\/jcb.28529","article-title":"c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer\/T-cell lymphoma","volume":"120","author":"Zhu","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"16","key":"10.1016\/j.prp.2024.155769_bib208","doi-asserted-by":"crossref","first-page":"9353","DOI":"10.3390\/ijms23169353","article-title":"Using ncRNAs as tools in Cancer diagnosis and treatment\u2014the way towards personalized medicine to improve patients\u2019 health","volume":"23","author":"Piergentili","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2024.155769_bib209","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3389\/fonc.2020.00898","article-title":"Genomics of peripheral T-cell lymphoma and its implications for personalized medicine","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2024.155769_bib210","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mjafi.2021.06.020","article-title":"Precision medicine: uses and challenges","volume":"77","author":"Naithani","year":"2021","journal-title":"Med. J. Armed Forces"},{"key":"10.1016\/j.prp.2024.155769_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.crbiot.2023.100150","article-title":"An insight of different classes of RNA-based therapeutic, nanodelivery and clinical status: current landscape","author":"Chatterjee","year":"2023","journal-title":"Curr. Res. Biotechnol."},{"key":"10.1016\/j.prp.2024.155769_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109997","article-title":"RNA-based pharmacotherapy for tumors: from bench to clinic and back","volume":"125","author":"Liang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.prp.2024.155769_bib213","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3390\/pharmaceutics15071972","article-title":"Recent advancement in mRNA vaccine development and applications","volume":"15","author":"Al Fayez","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T06:32:52Z","timestamp":1739255572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824006800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":213,"alternative-id":["S0344033824006800"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155769","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs and long non-coding RNAs In T-cell lymphoma: Mechanisms, pathway, therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155769"}}